Log In
BCIQ
Print this Print this
 

Macugen, pegaptanib (formerly NX1838)

Also known as: EYE001

  Manage Alerts
Collapse Summary General Information
Company Valeant Pharmaceuticals International Inc.
DescriptionPegylated oligonucleotide aptamer that binds to vascular endothelial growth factor-165 (VEGF-165)
Molecular Target Vascular endothelial growth factor (VEGF) 165
Mechanism of ActionVascular endothelial growth factor (VEGF) inhibitor
Therapeutic ModalityNucleic acid: Aptamer

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/13/2012

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today